Evidence map›Paper›PMID 26492479›Full record

ArticleAnesthesiology2015

Differential Efficacy of Ketamine in the Acute versus Chronic Stages of Complex Regional Pain Syndrome in Mice.

Maral Tajerian, David Leu, Phillip Yang, Ting Ting Huang, Wade S Kingery, J David Clark

Open access · greenAbstract readComparative Study
In one paragraph

Article in Anesthesiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Progress in palliation: Managing pain caused by cancer in veterinary medicine.The Canadian veterinary journal = La revue veterinaire canadienne · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. A Review of Nonanesthetic Uses of Ketamine.Anesthesiology research and practice · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Recurrent complex regional pain syndrome type I in a patient with amyotrophic lateral sclerosis: a case report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maral TajerianFrom the Veterans Affairs Palo Alto Health Care System, Palo Alto, California (M.T., J.D.C.); Department of Anesthesiology, Stanford University School of Medicine, Stanford, California (M.T., J.D.C.); Palo Alto Veterans Institute of Research and Education, Palo Alto, California (M.T., D.L., P.Y., T.T.H., J.D.C.); Geriatrics Research Education and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California (T.T.H.); Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California (D.L., P.Y., T.T.H.); and Physical Medicine and Rehabilitation Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California (W.S.K.).
David Leu
Phillip Yang
Ting Ting Huang
Wade S Kingery
J David Clark
Palo Alto Veterans Institute for Research · US

Funding

Mechanisms of Neuroinflammation after FractureR01NS072168 · NINDS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI KINGERY, WADE S · 2011 to 2014
$962k
NINDS NIH HHS NS072168NINDS NIH HHS R01 NS072168
6 · The paper itself

Abstract

backgroundComplex regional pain syndrome (CRPS) is a painful, disabling, and often chronic condition, where many patients transition from an acute phase with prominent peripheral neurogenic inflammation to a chronic phase with evident central nervous system changes. Ketamine is a centrally acting agent believed to work through blockade of N-methyl-D- aspartate receptors and is being increasingly used for the treatment of refractory CRPS, although the basis for the drug's effects and efficacy at different stages of the syndrome remains unclear.

methodsThe authors used a mouse model of CRPS (n = 8 to 12/group) involving tibia fracture/cast immobilization to test the efficacy of ketamine (2 mg kg day; 7 days) or vehicle infusion during acute (3 weeks after fracture) and chronic (7 weeks after fracture) stages.

resultsAcute-phase fracture mice displayed increased limb temperature, edema, and nociceptive sensitization that were not reduced by ketamine. Fracture mice treated with ketamine during the chronic phase showed reduced nociceptive sensitization that persisted beyond completion of the infusion. During this chronic phase, ketamine also reduced latent nociceptive sensitization and improved motor function at 18 weeks after fracture. No side effects of the infusions were identified. These behavioral changes were associated with altered spinal astrocyte activation and expression of pain-related proteins including N-methyl-D-aspartate receptor 2b, Ca/calmodulin-dependent protein kinase II, and brain-derived neurotrophic factor.

conclusionsCollectively, these results demonstrate that ketamine is efficacious in the chronic, but not acute, stage of CRPS, suggesting that the centrally acting drug is relatively ineffective in early CRPS when peripheral mechanisms are more critical for supporting nociceptive sensitization.

Indexed as

Acute DiseaseAnalgesicsAnimalsChronic DiseaseComplex Regional Pain SyndromesDisease Models, AnimalFollow-Up StudiesKetamineMaleMiceMice, Inbred C57BLTibial FracturesTreatment OutcomeAnalgesicsKetamine

Identifiers

PMID26492479
PMCPMC4679486
OpenAlexW2121100815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.